From: healthline.com A lumpectomy preserves more of your breast compared to a mastectomy. But you can choose a mastectomy that removes the entire breast or preserves the nipple and areola. Lumpectomy and mastectomy procedures are both performed to remove breast cancer. While both are effective, they have different benefits and risks. A lumpectomy preserves the breast, while a mastectomy removes all of …
TARGIT-IORT long-term data demonstrates equivalent outcomes to traditional 3- to 6-week radiotherapy, significantly reducing COVID-19 risk to patients amidst coming surge
Source: TARGIT Collaborative Group From: globenewswire.com The TARGIT Collaborative Group announced today that according to recent studies, an increase in the COVID-19 positivity rate correlates to an increase in mortality from non-coronavirus-related diseases. This includes breast cancer, and researchers believe fear of contracting the virus compels patients to stay home instead of seeking treatment or completing their many week course of …
Study: Targeted Radiotherapy for Breast Cancer Just as Effective as Conventional Radiotherapy
By: Sara Karlovitch, Assistant Editor From: pharmacytimes.com A single dose of targeted radiotherapy (TARGIT-IORT) during surgery is just as effective as conventional radiotherapy (EBRT) for most women with early breast cancer, a study published in The BMJ found. EBRT requires several trips to the hospital post-surgery and targets the entire breast. TARGIT-IORT, on the other hand, is given immediately after surgery and …
One-Off Blast of RT, Rather Than Weeks, for Early Breast Cancer
By: Sharon Worcester From: medscape.com Long-term outcomes now being reported confirm earlier reports from the same trial showing efficacy for the use of targeted intraoperative radiotherapy (TARGIT) in patients with early breast cancer. This novel approach, which delivers a one-off blast of radiation directed at the tumor bed and is given during lumpectomy, has similar efficacy and lowers non-breast cancer …
20% of women getting lumpectomies need a second surgery, but this risk can be lowered
By: Sheldon Feldman, M.D., F.A.C.S. From: sharsheret.org The lumpectomy procedure (sometimes referred to as Breast Conserving Surgery, or BCS) is the treatment of choice for many people with early-stage breast cancer. The surgeon seeks to remove the malignant tumor, while leaving behind as much healthy breast tissue as possible. Studies show that this procedure, when coupled with radiation, is …
Device helps breast cancer patients after surgery
By: Emily Linnert From: woodtv.com GRAND RAPIDS, Mich. (WOOD) — What looks like a small spiral of plastic has become a valuable tool for radiologists, oncologists and surgeons in the fight against breast cancer. Barbara Harvey has had an incredibly optimistic outlook when it comes to her fight with breast cancer. “When we all hear the ‘c’ word, we kind of panic, …
Local Surgeon Reports Positive Findings from Use of 3D Marker in Breast Cancer Treatment
Better Cosmetic Outcomes and Shorter Radiation Therapy Seen in Study Results A research study by local surgical oncologist Michael Cross, M.D., F.A.C.S., concluded that use of the BioZorb® surgical marker appears to provide better cosmetic outcomes and may be associated with an increased use of breast-conserving surgery in his practice. The study found that more than 90% of patients who …
Mastectomy vs. Lumpectomy for Early Breast Cancer: How to Choose
By: Deborah Kotz From: yahoo.com Each year more than 200,000 women diagnosed with early-stage breast cancer, the most common kind, must make myriad treatment decisions. Among them: whether to have a mastectomy or breast-conserving surgery known as a lumpectomy. If you’ve been diagnosed with a stage 1 or 2 breast tumor that’s not highly aggressive, you may have been offered …
Guidelines Aim to Reduce 2nd Surgeries After Breast Cancer Lumpectomy
By: Steven Reinberg From: .healthday.com In a study of more than 240,000 women who had breast conservation surgery for breast cancer, nearly 25 percent needed a second operation, a new study finds. “There are very few operations where you would expect to have a second surgery,” said lead researcher Dr. Lee Wilke, director of the section of surgical oncology at …
Walter Reed Bethesda Joins Novilase Clinical Trial
Groundbreaking Study of Laser Treatment for Breast Cancer Now Has 11 Active Trial Sites in United States and United Kingdom Novian Health, developer of Novilase® Breast Therapy, announced today that Walter Reed National Military Medical Center (Bethesda, Md.) is now a participating study site in the BR-002 Novilase Clinical Trial. The multi-center study is evaluating the effectiveness of Novilase Breast …
- Page 1 of 2
- 1
- 2